Adjusted EBITDA for the full year 2025 increased by $13.2 million, a 16.2% improvement over the prior year, reaching $95 million. Net revenue for 2025 grew by 16.3%, with the physical therapy business up 16% and injury prevention businesses up 18%. The company achieved record annual average visits per clinic per day of 32.2 in 2025, and a record 32.7 for the fourth quarter. Total patient visits increased 11.2% year-over-year, including a 1.5% increase at mature clinics for the full year, accelerating to 2.6% in Q4. Net rate per patient visit increased 1% for the full year 2025 to $105.76, and 1.7% in Q4 2025 to $106.49, despite Medicare rate reductions. Two significant long-term hospital affiliation arrangements were announced, expected to begin phasing in mid-2026 and contribute at least $14 million in enterprise EBITDA by 2027, with USPH's portion being over $7 million after minority interest. Strategic initiatives for 2026 include ambient listening documentation support, semi-virtualization of front desk operations, cash-based program expansion, remote therapeutic monitoring, and continued de novo and acquisition development. The company is implementing a new enterprise-wide financial and human resources system, with a go-live target of January 1, 2027, incurring $600,000 in implementation costs in Q4 2025.